investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Oak Ridge Investments LLC Q4 2022 vs. Q1 2023 13F Holdings Comparison

Ava Hoppe | 26 April, 2023

The latest 13F filings for Oak Ridge Investments LLC are out, revealing the fund's Q4 2022 and Q1 2023 holdings. While the overall changes in holdings have been minor, there have been some interesting movements within the portfolio. This blog post will provide an analysis of Oak Ridge Investments' Q4 2022 and Q1 2023 holdings and highlight the most prominent changes.

Introduction

Oak Ridge Investments is a Chicago-based investment management firm that specializes in growth equity investing. The firm was founded in 1989 and manages over $6 billion in assets. Oak Ridge's growth-oriented investment approach has produced impressive returns for investors over the years, and the latest 13F filings indicate the firm is still finding opportunities in the market.

The Holdings

The 13F filings report Oak Ridge's holdings as of the end of Q4 2022 and Q1 2023. Let's take a closer look at the top holdings in each period:

Q4 2022:

• Apple Inc (AAPL)

• Microsoft Corp (MSFT)

• Amazon.com Inc (AMZN)

• NVIDIA Corporation (NVDA)

• Lilly Eli & Co (LLY)

Q1 2023:

• Apple Inc (AAPL)

• Microsoft Corp (MSFT)

• Amazon.com Inc (AMZN)

• NVIDIA Corporation (NVDA)

• Meta Platforms Inc (META)

As we can see, there has been little change in Oak Ridge's top holdings between Q4 2022 and Q1 2023. However, there have been some notable movements that we will explore.

Prominent Changes

1. Meta Platforms

The most significant change in Oak Ridge's holdings between Q4 2022 and Q1 2023 is the addition of Meta Platforms Inc, formerly known as Facebook. Oak Ridge purchased 39,939 shares of the social media giant in Q1 2023, valued at $10,303,000. This is an increase of 91.6% compared to Q4 2022. This move suggests that Oak Ridge believes Meta Platforms has strong growth potential and is undervalued by the market.

2. Horizon Therapeutics Pub L

Oak Ridge sold 7.5% of its holding in Horizon Therapeutics Pub L between Q4 2022 and Q1 2023. The fund now holds 69,276 shares, valued at $7,560,000. This represents a 7% decrease in shareholding and value. It could be that Oak Ridge reallocated funds into other holdings it believed would perform better, or the fund could have taken profits from the stock's recent growth.

3. Matador Res Co

Oak Ridge reduced its holding in Matador Res Co between Q4 2022 and Q1 2023, selling 6.1% of its shareholding. The fund now holds 104,715 shares, valued at $4,989,000. This is a significant decrease from the previous quarter, with the value of the holding down by 21.6%. This reduction in shareholding could be due to a lack of confidence in the performance of the energy sector or a reallocation of funds to other positions.

Conclusion

The latest 13F filings for Oak Ridge Investments LLC show that the fund has made some interesting movements in its holdings between Q4 2022 and Q1 2023. While the overall changes have been minor, there have been some prominent movements. Oak Ridge has added Meta Platforms to its holdings and reduced holdings in Horizon Therapeutics Pub L and Matador Res Co. These changes suggest that Oak Ridge has faith in the continued growth potential of the technology sector while showing some caution in the performance of other sectors. As always, it will be interesting to see how these moves play out in the coming months.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.